EDGAR Filing Documents for 0001144204-15-068083

Form 8-K - Current report:

SEC Accession No. 0001144204-15-068083

Filing Date

2015-11-25

Accepted

2015-11-25 16:05:31

Documents

Period of Report

2015-11-19

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v425686_8k.htm	8-K	23752
2	EXHIBIT 10.1	v425686_ex10-1.htm	EX-10.1	20573
	Complete submission text file	0001144204-15-068083.txt		45609

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 151256279
SIC: 2834 Pharmaceutical Preparations